How has DISC1 enabled drug discovery?

Molecular and Cellular Neuroscience

Volumn 37, Issue 2, 2008, Pages 187-195

  Wang, Qi ^a   Jaaro Peled, Hanna ^b   Sawa, Akira ^b   Brandon, Nicholas J ^a  

^a PFIZER INC   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal models; DISC1; Nudel Ndel1; PDE4; Psychiatric disorders; Schizophrenia

Indexed keywords

COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; ENDO OLIGOPEPTIDASE A; PEPTIDASE; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IVB; PROTEIN KINASE (CALCIUM,CALMODULIN); ROLIPRAM; UNCLASSIFIED DRUG;

ARTERITIS; BIOLOGY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MODEL; DISRUPTED IN SCHIZOPHRENIA 1 GENE; GENE; GENE EXPRESSION; GENE INTERACTION; GENE LOCATION; HUMAN; MENTAL DISEASE; NERVE GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; RNA INTERFERENCE; SYNAPSE; VOMITING;

ANIMALS; BRAIN; CARRIER PROTEINS; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; DISEASE MODELS, ANIMAL; DRUG DESIGN; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NERVE TISSUE PROTEINS; SYNAPTIC TRANSMISSION;

ANIMALIA;

EID: 38649109079     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2007.10.006     Document Type: Review

References (83)

1. Austin C.P., Ma L., Ky B., Morris J.A., and Shughrue P.J. DISC1 (disrupted in schizophrenia-1) is expressed in limbic regions of the primate brain. NeuroReport 14 (2003) 951-954
2. Blackwood D.H., Fordyce A., Walker M.T., St Clair D.M., Porteous D.J., and Muir W.J. Schizophrenia and affective disorders-cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am. J. Hum. Genet. 69 (2001) 428-433
3. Bord L., Wheeler J., Paek M., Saleh M., Lyons-Warren A., Ross C.A., Sawamura N., and Sawa A. Primate disrupted-in-schizophrenia-1 (DISC1): high divergence of a gene for major mental illnesses in recent evolutionary history. Neurosci. Res. 56 (2006) 286-293
4. Boules M., Shaw A., Fredrickson P., and Richelson E. Neurotensin agonists: potential in the treatment of schizophrenia. CNS Drugs 21 (2007) 13-23
5. Brandon, N.J., Rotella, D.P., in press. Potential CNS applications for phosphodiesterase enzyme inhibitors. Annu. Rep. Med. Chem.
6. Brandon N.J., Handford E.J., Schurov I., Rain J.C., Pelling M., Duran-Jimeniz B., Camargo L.M., Oliver K.R., Beher D., Shearman M.S., and Whiting P.J. Disrupted in schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders. Mol. Cell. Neurosci. 25 (2004) 42-55
7. Bromme D., and Kaleta J. Thiol-dependent cathepsins: pathophysiological implications and recent advances in inhibitor design. Curr. Pharm. Des. 8 (2002) 1639-1658
8. Burdick K.E., Hodgkinson C.A., Szeszko P.R., Lencz T., Ekholm J.M., Kane J.M., Goldman D., and Malhotra A.K. DISC1 and neurocognitive function in schizophrenia. NeuroReport 16 (2005) 1399-1402
9. Burgin K.E., Waxham M.N., Rickling S., Westgate S.A., Mobley W.C., and Kelly P.T. In situ hybridization histochemistry of Ca2+/calmodulin-dependent protein kinase in developing rat brain. J. Neurosci. 10 (1990) 1788-1798
10. Byk T., Dobransky T., Cifuentes-Diaz C., and Sobel A. Identification and molecular characterization of Unc-33-like phosphoprotein (Ulip), a putative mammalian homolog of the axonal guidance-associated unc-33 gene product. J. Neurosci. 16 (1996) 688-701
11. Callicott J.H., Straub R.E., Pezawas L., Egan M.F., Mattay V.S., Hariri A.R., Verchinski B.A., Meyer-Lindenberg A., Balkissoon R., Kolachana B., Goldberg T.E., and Weinberger D.R. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 8627-8632
12. Camargo L.M., Collura V., Rain J.C., Mizuguchi K., Hermjakob H., Kerrien S., Bonnert T.P., Whiting P.J., and Brandon N.J. Disrupted in schizophrenia 1 interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Mol. Psychiatry 12 (2007) 74-86
13. Cannon T.D., Hennah W., van Erp T.G., Thompson P.M., Lonnqvist J., Huttunen M., Gasperoni T., Tuulio-Henriksson A., Pirkola T., Toga A.W., Kaprio J., Mazziotta J., and Peltonen L. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch. Gen. Psychiatry 62 (2005) 1205-1213
14. Chen Q.Y., Chen Q., Feng G.Y., Lindpaintner K., Wang L.J., Chen Z.X., Gao Z.S., Tang J.S., Huang G., and He L. Case-control association study of disrupted-in-schizophrenia-1 (DISC1) gene and schizophrenia in the Chinese population. J. Psychiatr. Res. 41 (2007) 428-434
15. Clapcote S.J., and Roder J.C. Deletion polymorphism of DISC1 is common to all 129 mouse substrains: implications for gene-targeting studies of brain function. Genetics 173 (2006) 2407-2410
16. Clapcote S.J., Lipina T.V., Millar J.K., Mackie S., Christie S., Ogawa F., Lerch J.P., Trimble K., Uchiyama M., Sakuraba Y., Kaneda H., Shiroishi T., Houslay M.D., Henkelman R.M., Sled J.G., Gondo Y., Porteous D.J., and Roder J.C. Behavioral phenotypes of DISC1 missense mutations in mice. Neuron 54 (2007) 387-402
17. Corcoran E.E., and Means A.R. Defining Ca2+/calmodulin-dependent protein kinase cascades in transcriptional regulation. J. Biol. Chem. 276 (2001) 2975-2978
18. Craddock N., O'Donovan M.C., and Owen M.J. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr. Bull. 32 (2006) 9-16
19. Dastidar S.G., Rajagopal D., and Ray A. Therapeutic benefit of PDE4 inhibitors in inflammatory diseases. Curr. Opin. Investig. Drugs 8 (2007) 364-372
20. Duan X., Chang J.H., Ge S., Faulkner R.L., Kim J.Y., Kitabatake Y., Liu X.B., Yang C.H., Jordan J.D., Ma D.K., Liu C.Y., Ganesan S., Cheng H.J., Ming G.L., Lu B., and Song H. Disrupted-in-schizophrenia 1 regulates integration of newly generated neurons in the adult brain. Cell 130 (2007) 1146-1158
21. Ekelund J., Hovatta I., Parker A., Paunio T., Varilo T., Martin R., Suhonen J., Ellonen P., Chan G., Sinsheimer J.S., Sobel E., Juvonen H., Arajarvi R., Partonen T., Suvisaari J., Lonnqvist J., Meyer J., and Peltonen L. Chromosome 1 loci in Finnish schizophrenia families. Hum. Mol. Genet. 10 (2001) 1611-1617
22. Ekelund J., Hennah W., Hiekkalinna T., Parker A., Meyer J., Lonnqvist J., and Peltonen L. Replication of 1q42 linkage in Finnish schizophrenia pedigrees. Mol. Psychiatry 9 (2004) 1037-1041
23. Erhardt A., Lucae S., Unschuld P.G., Ising M., Kern N., Salyakina D., Lieb R., Uhr M., Binder E.B., Keck M.E., Muller-Myhsok B., and Holsboer F. Association of polymorphisms in P2RX7 and CaMKKb with anxiety disorders. J. Affect. Disord. 101 (2007) 159-168
24. Gandhi T.K., Zhong J., Mathivanan S., Karthick L., Chandrika K.N., Mohan S.S., Sharma S., Pinkert S., Nagaraju S., Periaswamy B., Mishra G., Nandakumar K., Shen B., Deshpande N., Nayak R., Sarker M., Boeke J.D., Parmigiani G., Schultz J., Bader J.S., and Pandey A. Analysis of the human protein interactome and comparison with yeast, worm and fly interaction datasets. Nat. Genet. 38 (2006) 285-293
25. Giembycz M.A. Life after PDE4: overcoming adverse events with dual-specificity phosphodiesterase inhibitors. Curr. Opin. Pharmacol. 5 (2005) 238-244
26. Goshima Y., Nakamura F., Strittmatter P., and Strittmatter S.M. Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature 376 (1995) 509-514
27. Gould T.D., and Manji H.K. Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology 30 (2005) 1223-1237
28. Hamajima N., Matsuda K., Sakata S., Tamaki N., Sasaki M., and Nonaka M. A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution. Gene 180 (1996) 157-163
29. Hamshere M.L., Bennett P., Williams N., Segurado R., Cardno A., Norton N., Lambert D., Williams H., Kirov G., Corvin A., Holmans P., Jones L., Jones I., Gill M., O'Donovan M.C., Owen M.J., and Craddock N. Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. Arch. Gen. Psychiatry 62 (2005) 1081-1088
30. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10 (2005) 40-68 (image 45)
31. Hayashi M.A., Portaro F.C., Bastos M.F., Guerreiro J.R., Oliveira V., Gorrao S.S., Tambourgi D.V., Sant'Anna O.A., Whiting P.J., Camargo L.M., Konno K., Brandon N.J., and Camargo A.C. Inhibition of NUDEL (nuclear distribution element-like)-oligopeptidase activity by disrupted-in-schizophrenia 1. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3828-3833
32. Hennah W., Varilo T., Kestila M., Paunio T., Arajarvi R., Haukka J., Parker A., Martin R., Levitzky S., Partonen T., Meyer J., Lonnqvist J., Peltonen L., and Ekelund J. Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum. Mol. Genet. 12 (2003) 3151-3159
33. Hennah W., Tuulio-Henriksson A., Paunio T., Ekelund J., Varilo T., Partonen T., Cannon T.D., Lonnqvist J., and Peltonen L. A haplotype within the DISC1 gene is associated with visual memory functions in families with a high density of schizophrenia. Mol. Psychiatry 10 (2005) 1097-1103
34. Hennah W., Tomppo L., Hiekkalinna T., Palo O.M., Kilpinen H., Ekelund J., Tuulio-Henriksson A., Silander K., Partonen T., Paunio T., Terwilliger J.D., Lonnqvist J., and Peltonen L. Families with the risk allele of DISC1 reveal a link between schizophrenia and another component of the same molecular pathway, NDE1. Hum. Mol. Genet. 16 (2007) 453-462
35. Hikida T., Jaaro-Peled H., Seshadri S., Oishi K., Hookway C., Kong S., Wu D., Xue R., Andrade M., Tankou S., Mori S., Gallagher M., Ishizuka K., Pletnikov M., Kida S., and Sawa A. Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 14501-14506
36. Hodgkinson C.A., Goldman D., Jaeger J., Persaud S., Kane J.M., Lipsky R.H., and Malhotra A.K. Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am. J. Hum. Genet. 75 (2004) 862-872
37. Hodgkinson C.A., Goldman D., Ducci F., DeRosse P., Caycedo D.A., Newman E.R., Kane J.M., Roy A., and Malhotra A.K. The FEZ1 gene shows no association to schizophrenia in Caucasian or African American populations. Neuropsychopharmacology 32 (2007) 190-196
38. Inagaki N., Chihara K., Arimura N., Menager C., Kawano Y., Matsuo N., Nishimura T., Amano M., and Kaibuchi K. CRMP-2 induces axons in cultured hippocampal neurons. Nat. Neurosci. 4 (2001) 781-782
39. Ishizuka K., Paek M., Kamiya A., and Sawa A. A review of disrupted-in-schizophrenia-1 (DISC1): neurodevelopment, cognition, and mental conditions. Biol. Psychiatry 59 (2006) 1189-1197
40. Ishizuka K., Chen J., Taya S., Li W., Millar J.K., Xu Y., Clapcote S.J., Hookway C., Morita M., Kamiya A., Tomoda T., Lipska B.K., Roder J.C., Pletnikov M., Porteous D., Silva A.J., Cannon T.D., Kaibuchi K., Brandon N.J., Weinberger D.R., and Sawa A. Evidence that many of the DISC1 isoforms in C57BL/6J mice are also expressed in 129S6/SvEv mice. Mol. Psychiatry 12 (2007) 897-899
41. James R., Adams R.R., Christie S., Buchanan S.R., Porteous D.J., and Millar J.K. Disrupted in Schizophrenia 1 (DISC1) is a multicompartmentalized protein that predominantly localizes to mitochondria. Mol. Cell. Neurosci. 26 (2004) 112-122
42. Johnston-Wilson N.L., Sims C.D., Hofmann J.P., Anderson L., Shore A.D., Torrey E.F., and Yolken R.H. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol. Psychiatry 5 (2000) 142-149
43. Kamiya A., Kubo K., Tomoda T., Takaki M., Youn R., Ozeki Y., Sawamura N., Park U., Kudo C., Okawa M., Ross C.A., Hatten M.E., Nakajima K., and Sawa A. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat. Cell Biol. 7 (2005) 1167-1178
44. Kamiya A., Tomoda T., Chang J., Takaki M., Zhan C., Morita M., Cascio M.B., Elashvili S., Koizumi H., Takanezawa Y., Dickerson F., Yolken R., Arai H., and Sawa A. DISC1-NDEL1/NUDEL protein interaction, an essential component for neurite outgrowth, is modulated by genetic variations of DISC1. Hum. Mol. Genet. 15 (2006) 3313-3323
45. Kirkpatrick B., Xu L., Cascella N., Ozeki Y., Sawa A., and Roberts R.C. DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex. J. Comp. Neurol. 497 (2006) 436-450
46. Koike H., Arguello P.A., Kvajo M., Karayiorgou M., and Gogos J.A. DISC1 is mutated in the 129S6/SvEv strain and modulates working memory in mice. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 3693-3697
47. Lewis D.A., Hashimoto T., and Volk D.W. Cortical inhibitory neurons and schizophrenia. Nat. Rev., Neurosci. 6 (2005) 312-324
48. Li W., Zhou Y., Brown R.A., Ehninger D., Tian X., Trachtenberg J., Jentsch J.D., Silva A.J., and Cannon T.D. Characterization of the inducible DISC1 mutant mice. Society for Neuroscience meeting (2006) Atlanta 2006 Program 763.13
49. Liu Y.L., Fann C.S., Liu C.M., Chen W.J., Wu J.Y., Hung S.I., Chen C.H., Jou Y.S., Liu S.K., Hwang T.J., Hsieh M.H., Ouyang W.C., Chan H.Y., Chen J.J., Yang W.C., Lin C.Y., Lee S.F., and Hwu H.G. A single nucleotide polymorphism fine mapping study of chromosome 1q42.1 reveals the vulnerability genes for schizophrenia, GNPAT and DISC1: association with impairment of sustained attention. Biol. Psychiatry 60 (2006) 554-562
50. Ma L., Liu Y., Ky B., Shughrue P.J., Austin C.P., and Morris J.A. Cloning and characterization of DISC1, the mouse ortholog of DISC1 (disrupted-in-schizophrenia 1). Genomics 80 (2002) 662-672
51. Macgregor S., Visscher P.M., Knott S.A., Thomson P., Porteous D.J., Millar J.K., Devon R.S., Blackwood D., and Muir W.J. A genome scan and follow-up study identify a bipolar disorder susceptibility locus on chromosome 1q42. Mol. Psychiatry 9 (2004) 1083-1090
52. Maeda K., Nwulia E., Chang J., Balkissoon R., Ishizuka K., Chen H., Zandi P., McInnis M.G., and Sawa A. Differential expression of disrupted-in-schizophrenia (DISC1) in bipolar disorder. Biol. Psychiatry 60 (2006) 929-935
53. Menniti F.S., Faraci W.S., and Schmidt C.J. Phosphodiesterases in the CNS: targets for drug development. Nat. Rev. Drug Discov. 5 (2006) 660-670
54. Millar J.K., Christie S., Semple C.A., and Porteous D.J. Chromosomal location and genomic structure of the human translin-associated factor X gene (TRAX; TSNAX) revealed by intergenic splicing to DISC1, a gene disrupted by a translocation segregating with schizophrenia. Genomics 67 (2000) 69-77
55. Millar J.K., Wilson-Annan J.C., Anderson S., Christie S., Taylor M.S., Semple C.A., Devon R.S., Clair D.M., Muir W.J., Blackwood D.H., and Porteous D.J. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet. 9 (2000) 1415-1423
56. Millar J.K., Christie S., Anderson S., Lawson D., Hsiao-Wei Loh D., Devon R.S., Arveiler B., Muir W.J., Blackwood D.H., and Porteous D.J. Genomic structure and localisation within a linkage hotspot of disrupted in schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia. Mol. Psychiatry 6 (2001) 173-178
57. Millar J.K., Pickard B.S., Mackie S., James R., Christie S., Buchanan S.R., Malloy M.P., Chubb J.E., Huston E., Baillie G.S., Thomson P.A., Hill E.V., Brandon N.J., Rain J.C., Camargo L.M., Whiting P.J., Houslay M.D., Blackwood D.H., Muir W.J., and Porteous D.J. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 310 (2005) 1187-1191
58. Minturn J.E., Fryer H.J., Geschwind D.H., and Hockfield S. TOAD-64, a gene expressed early in neuronal differentiation in the rat, is related to unc-33, a C. elegans gene involved in axon outgrowth. J. Neurosci. 15 (1995) 6757-6766
59. Miyoshi K., Honda A., Baba K., Taniguchi M., Oono K., Fujita T., Kuroda S., Katayama T., and Tohyama M. Disrupted-in-schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth. Mol. Psychiatry 8 (2003) 685-694
60. Murdoch H., Mackie S., Collins D.M., Hill E.V., Bolger G.B., Klussmann E., Porteous D.J., Millar J.K., and Houslay M.D. Isoform-selective susceptibility of DISC1/phosphodiesterase-4 complexes to dissociation by elevated intracellular cAMP levels. J. Neurosci. 27 (2007) 9513-9524
61. Nakata K., Ujike H., Sakai A., Takaki M., Imamura T., Tanaka Y., and Kuroda S. The human dihydropyrimidinase-related protein 2 gene on chromosome 8p21 is associated with paranoid-type schizophrenia. Biol. Psychiatry 53 (2003) 571-576
62. Ozeki Y., Tomoda T., Kleiderlein J., Kamiya A., Bord L., Fujii K., Okawa M., Yamada N., Hatten M.E., Snyder S.H., Ross C.A., and Sawa A. Disrupted-in-schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 289-294
63. Pangalos M.N., Schechter L.E., and Hurko O. Drug development for CNS disorders: strategies for balancing risk and reducing attrition. Nat. Rev. Drug Discov. 6 (2007) 521-532
64. Peters M., Mizuno K., Ris L., Angelo M., Godaux E., and Giese K.P. Loss of Ca2+/calmodulin kinase kinase beta affects the formation of some, but not all, types of hippocampus-dependent long-term memory. J. Neurosci. 23 (2003) 9752-9760
65. Pletnikov M.V., Xu Y., Ovanesov M.V., Kamiya A., Sawa A., and Ross C.A. PC12 cell model of inducible expression of mutant DISC1: new evidence for a dominant-negative mechanism of abnormal neuronal differentiation. Neurosci. Res. 58 (2007) 234-244
66. Pletnikov M.V., Ayhan Y., Nikolskaia O., Xu Y., Ovanesov M.V., Huang H., Mori S., Moran T.H., and Ross C.A. Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol. Psychiatry (2007) (Electronic publication ahead of print)
67. Porteous D.J., Thomson P., Brandon N.J., and Millar J.K. The genetics and biology of DISC1-an emerging role in psychosis and cognition. Biol. Psychiatry 60 (2006) 123-131
68. Qu M., Tang F., Yue W., Ruan Y., Lu T., Liu Z., Zhang H., Han Y., Zhang D., Wang F., and Zhang D. Positive association of the disrupted-in-schizophrenia-1 gene (DISC1) with schizophrenia in the Chinese Han population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144 (2007) 266-270
69. Sawa A., and Snyder S.H. Genetics. Two genes link two distinct psychoses. Science 310 (2005) 1128-1129
70. Sawamura N., Sawamura-Yamamoto T., Ozeki Y., Ross C.A., and Sawa A. A form of DISC1 enriched in nucleus: altered subcellular distribution in orbitofrontal cortex in psychosis and substance/alcohol abuse. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1187-1192
71. Schurov I.L., Handford E.J., Brandon N.J., and Whiting P.J. Expression of disrupted in schizophrenia 1 (DISC1) protein in the adult and developing mouse brain indicates its role in neurodevelopment. Mol. Psychiatry 9 (2004) 1100-1110
72. Shenton M.E., Dickey C.C., Frumin M., and McCarley R.W. A review of MRI findings in schizophrenia. Schizophr. Res. 49 (2001) 1-52
73. Siuciak J.A., Chapin D.S., McCarthy S.A., and Martin A.N. Antipsychotic profile of rolipram: efficacy in rats and reduced sensitivity in mice deficient in the phosphodiesterase-4B (PDE4B) enzyme. Psychopharmacology (Berl.) 192 (2007) 415-424
74. Taya S., Shinoda T., Tsuboi D., Asaki J., Nagai K., Hikita T., Kuroda S., Kuroda K., Shimizu M., Hirotsune S., Iwamatsu A., and Kaibuchi K. DISC1 regulates the transport of the NUDEL/LIS1/14-3-3epsilon complex through kinesin-1. J. Neurosci. 27 (2007) 15-26
75. Taylor M.S., Devon R.S., Millar J.K., and Porteous D.J. Evolutionary constraints on the disrupted in schizophrenia locus. Genomics 81 (2003) 67-77
76. Thomson P.A., Harris S.E., Starr J.M., Whalley L.J., Porteous D.J., and Deary I.J. Association between genotype at an exonic SNP in DISC1 and normal cognitive aging. Neurosci. Lett. 389 (2005) 41-45
77. Thomson P.A., Wray N.R., Millar J.K., Evans K.L., Hellard S.L., Condie A., Muir W.J., Blackwood D.H., and Porteous D.J. Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population. Mol. Psychiatry 10 (2005) 657-668 (616)
78. Turnbull G., and Bebbington P. Anxiety and the schizophrenic process: clinical and epidemiological evidence. Soc. Psychiatry Psychiatr. Epidemiol. 36 (2001) 235-243
79. Ujike H., Sakai A., Nakata K., Tanaka Y., Kodaka T., Okahisa Y., Harano M., Inada T., Yamada M., Komiyama T., Hori T., Sekine Y., Iwata N., Sora I., Iyo M., Ozaki N., and Kuroda S. Association study of the dihydropyrimidinase-related protein 2 gene and methamphetamine psychosis. Ann. N.Y. Acad. Sci. 1074 (2006) 90-96
80. Wang H., Peng M., Chen Y., Geng J., Robinson H., Houslay M.D., Cai J., and Ke H. Structures of the four subfamilies of phosphodiesterase-4 provide insight into the selectivity of their inhibitors. Biochem. J. 408 (2007) 193-201
81. Zhang K.Y., Ibrahim P.N., Gillette S., and Bollag G. Phosphodiesterase-4 as a potential drug target. Expert Opin. Ther. Targets 9 (2005) 1283-1305
82. Zhang F., Sarginson J., Crombie C., Walker N., St Clair D., and Shaw D. Genetic association between schizophrenia and the DISC1 gene in the Scottish population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141 (2006) 155-159
83. Zhao X., Tang R., Xiao Z., Shi Y., Feng G., Gu N., Shi J., Xing Y., Yan L., Sang H., Zhu S., Liu H., Chen W., Liu J., Tang W., Zhang J., and He L. An investigation of the dihydropyrimidinase-like 2 (DPYSL2) gene in schizophrenia: genetic association study and expression analysis. Int. J. Neuropsychopharmacol. 9 (2006) 705-712